The information you are about to be referred to may not comply with the Australian regulatory requirements and does not replace medical advice from a healthcare professional. Further information for medication relevant to the Australian environment is available from the consumer medicine information for the associated medication which can be found on www.viivhealthcare.com.au/ or by consulting a healthcare professional.

Explore ViiV Healthcare

...looking for

...looking for ▾

information about VHC medicines
clinical data and insights on VHC medicines
Independent Medical Education
medicines in development
how VHC is advancing HIV treatment and care

...looking for

...looking for ▾

information about VHC medicines
information and support about living with HIV
how to report a side effect
news and stories from ViiV Healthcare

...looking for

...looking for ▾

funding / grants
ViiV Healthcare's approach to partnerships
how ViiV Healthcare works with NGOs
news and stories from ViiV Healthcare
connect with ViiV Healthcare's community

...looking for

...looking for ▾

job opportunities
information about ViiV Healthcare
ViiV Healthcare's office locations
news and stories from ViiV Healthcare

...looking for

...looking for ▾

who are ViiV Healthcare
corporate ethics & compliance
news and stories from ViiV Healthcare

...looking for

...looking for ▾

opportunities to partner with ViiV Healthcare
information on ViiV Healthcare's Innovation Unit
news and stories from ViiV Healthcare

...looking for

...looking for ▾

press releases
ViiV Healthcare's Leadership
news and stories from ViiV Healthcare

ViiV News

Press releases

Filter by year Filter by year

Search by keyword Search by keyword

New, once-daily, single-pill approved to address changing HIV needs in Australia

19 Sep 2019
First two drug pill now available for Australians with HIV

29 Nov 2018
First two drug single pill for HIV now approved for use in Australia

23 Jul 2018
ViiV Healthcare awards new grants to accelerate community led solutions to HIV challenges

23 Oct 2017
Critical Steps Towards Addressing HIV in Australia a report from ViiV Healthcare Australia

05 Sep 2017
Grassroots HIV organisations receive 140 000 funding boost

10 Mar 2016
ViiV Healthcare to progress collaboration with Janssen to develop the first long-acting two drug injectable regimen for treatment of HIV

10 Mar 2016

ViiV Healthcare; Janssen; HIV; HIV-1; dolutegravir; tivicay; two drug injectable regimen; cabotegravir; rilpivirine; viral suppression; phase III
2016
March
September
October
2017

Media contacts

For Australia-specific media enquiries please contact Bill Paterson.

M: +61 478 261 568

E: bill.x.paterson@viivhealthcare.com

Date of Preparation: August 2017 | AUS/HIV/0093/17

©2018 ViiV Healthcare.

Copyright 2016 ViiV Healthcare Pty Ltd – All Rights Reserved | Registered Office Level 3, 436 Johnston Street, Abbotsford, VIC 3067 | Date of Preparation: March 2016 AUS/HIV/0016/13(3)d | For information on ViiV Healthcare products or to report an adverse event involving a ViiV product, please contact GSK Medical Information on 1800 499 226